Aspergillosis & Asthma: When Risks Peak Through the Year

Many people living with aspergillosis, asthma, or bronchiectasis notice that their symptoms change with the seasons.
This is no coincidence — environmental factors such as temperature, humidity, pollen, spores, and viral infections all vary through the year, and these can strongly influence both lung health and allergic or fungal disease.

Understanding these patterns can help you plan ahead, reduce exposure, and know when to take extra care.

🌸 Spring: Pollen and Early Spore Season

As temperatures rise, tree pollen (especially birch, oak, and plane) and Aspergillus spores begin to increase in outdoor air.
For people with Allergic Bronchopulmonary Aspergillosis (ABPA) or Severe Asthma with Fungal Sensitisation (SAFS), this can trigger cough, wheeze, and chest tightness.

  • Keep an eye on Met Office pollen and spore forecasts.

  • Open windows on dry days, but check for signs of mould indoors, especially around windows and bathrooms.

  • If you notice symptoms flaring every spring, let your respiratory team know — small medication adjustments may help.

📊 Data source: Met Office spore count data.

☀️ Summer: Soil, Compost, and Renovation Hazards

Warm, humid conditions mean fungi thrive — especially outdoors.
Compost heaps, garden soil, and grass cuttings can release very high levels of Aspergillus spores.
People with chronic lung disease, ABPA, or Chronic Pulmonary Aspergillosis (CPA) are at greater risk of exacerbations during this period.

  • If gardening or using compost, wear gloves and an FFP2/FFP3 mask.

  • Avoid turning compost heaps or cleaning bird feeders if you are immunocompromised.

  • Keep home humidity below 60% and ventilate well during warm spells.

🪴 Source: Protective mask and compost safety advice.

🍂 Autumn: Damp Homes and Viral Load

As the weather cools, we close windows and turn on heating — trapping moisture indoors.
This increases damp and mould growth, particularly in poorly ventilated areas.
At the same time, colds, flu, and RSV infections surge, all of which can make fungal or allergic conditions worse.

  • Use a dehumidifier and ensure air can circulate behind furniture.

  • Check for leaks, condensation, or cold corners.

  • Stay up to date with flu and COVID vaccinations if eligible.

💧 Source: Aspergillosis.org damp guidance.

❄️ Winter: Indoor Season and Medication Review

Outdoor spore levels are lowest in winter, but indoor exposure dominates — from bathrooms, humidifiers, and heating systems.
Viral infections remain a major trigger for asthma and ABPA flare-ups, and antifungal or steroid treatments may need review.

  • Keep homes warm but ventilated where possible.

  • Review your treatment plan with your clinical team, especially if you’re using steroids or biologics.

  • Contact your GP or specialist early if you notice an increase in cough, breathlessness, or mucus plugs.

🧭 Key Takeaway

Aspergillosis and asthma flare-ups often follow the seasons:

Season Main Risks Take Action
Spring Pollen, outdoor spores Monitor counts, check home for mould
Summer Compost, soil, renovation dust Use masks/gloves, avoid heavy exposure
Autumn Damp homes, viruses Dehumidify, ventilate, manage infections
Winter Indoor air, viruses Keep warm, review treatment

By spotting your personal pattern, you and your care team can plan ahead — reducing exacerbations and staying well all year.

by GAtherton

🫁 Understanding Chronic Cough in Aspergillosis

What the latest British Thoracic Society statement means for you

🌬️ Why This Matters

If you live with aspergillosis, Allergic Bronchopulmonary Aspergillosis (ABPA), or bronchiectasis, coughing can dominate your life. It’s tiring, painful, and socially awkward — especially when people assume it means infection.

Doctors used to see cough as just a symptom of another problem, but the British Thoracic Society (BTS) Clinical Statement on Chronic Cough in Adults (2023) recognises something new:

For many people, a cough can become a condition in its own right — caused by airway and nerve hypersensitivity, not just infection.

This matters for aspergillosis patients because fungal allergy and inflammation make the airways especially sensitive.

💡 What Is “Chronic Cough”?

A chronic cough is one lasting eight weeks or more.
It may be:

  • Dry – little or no mucus

  • Productive – thick sputum (common in bronchiectasis or chronic aspergillosis)

  • Triggered by dust, cold air, perfume, or strong scents

For people with aspergillosis, several overlapping causes may exist:

  • Fungal colonisation or infection

  • Allergic inflammation (ABPA)

  • Bronchiectasis and mucus retention

  • Reflux or post-nasal drip

  • Nerve hypersensitivity

This is why one treatment rarely fixes everything — different “treatable traits” must be addressed together.

🧬 Why It Happens

1️⃣ The Hypersensitive Cough Reflex

People with aspergillosis often develop overactive airway nerves — so normal irritants like dust, scent, or cold air trigger coughing fits.

This “cough reflex hypersensitivity” happens because:

  • Ongoing inflammation damages the airway lining.

  • Nerve endings in the throat and lungs become over-responsive.

  • Even mild triggers set off powerful reflexes.

This is a real physiological process, not psychological.
It’s why cough can continue even when infection is under control.

2️⃣ Treatable Traits – Finding the Real Drivers

Treatable Trait What It Means What Helps
Airway infection or colonisation Persistent fungi or bacteria Antifungal or antibiotic therapy, sputum tests
Allergic inflammation ABPA or asthma-type airway swelling Corticosteroids, biologics (e.g., mepolizumab, benralizumab)
Cough reflex hypersensitivity Overactive airway nerves Speech therapy, nerve-modulating medication
Airway clearance problems Mucus that’s hard to shift Physiotherapy, saline or mucolytic therapy
Reflux or postnasal drip Acid or sinus drainage irritation Reflux management, ENT care

Identifying these traits helps your clinician personalise treatment.

💊 Medications That Can Cause or Worsen Cough

The BTS statement highlights that some medicines can trigger or amplify chronic cough — especially in people with already-sensitive lungs.

🔹 ACE Inhibitors (Blood pressure or heart disease)

Examples: Ramipril, Lisinopril, Enalapril, Perindopril

  • Can cause a dry, tickly cough due to bradykinin build-up.

  • Happens in ~1 in 5 users, sometimes months after starting.

  • GP can switch to a similar drug (ARB – e.g., losartan) that doesn’t cause cough.

🔹 Beta Blockers (Heart or migraine medicines)

Examples: Atenolol, Propranolol, Bisoprolol

  • May tighten airways, worsening wheeze or cough.

  • Safer “lung-selective” versions exist but should still be monitored.

🔹 Inhalers

Examples: Fluticasone, Budesonide, Salbutamol

  • Can irritate the throat if used without a spacer or if technique is poor.

  • Always rinse or gargle after use, and ask your pharmacist to review inhaler technique.

🔹 Antifungal or Reflux Medicines

  • Antifungals (itraconazole, voriconazole) don’t directly cause cough, but reflux or nausea can trigger coughing indirectly.

  • PPIs (omeprazole, lansoprazole) usually help reflux-related cough, but long-term use should be reviewed regularly.

🔹 Other Drugs

  • Amiodarone, methotrexate, and some biologics can rarely cause cough due to lung inflammation.

  • Nasal sprays or lozenges with menthol/alcohol may irritate already-sensitive airways.

💬 If you suspect a medicine is contributing, don’t stop it suddenly — speak to your doctor or pharmacist first.
They can review interactions using the
👉 BNF Interactions Checker – NICE Medicines Guidance.

🔍 How Doctors Assess Chronic Cough

BTS recommends a structured pathway:

  1. Basic tests: chest X-ray, spirometry, bloods (eosinophils, IgE), FeNO if available.

  2. Further tests: CT scan, allergy or sputum studies if initial tests are abnormal.

  3. Trait-based review: identifying overlapping issues — fungal, allergic, nerve-related, or reflux-related.

  4. Specialist referral: to a Cough Clinic or Aspergillosis Centre if symptoms persist.

🧴 Pharmacists: Your Safety Specialists

Pharmacists — hospital or community — are crucial for managing long-term cough and medication safety:

  • Check for cough-inducing drugs or interactions.

  • Advise on best timing for antifungal and steroid doses.

  • Help switch to fragrance-free personal or cleaning products.

  • Liaise with your GP and consultant to fine-tune treatment.

🧭 Regular medication reviews every few months can prevent small problems becoming major triggers.

💬 How It Feels — and Why It’s Misunderstood

People with aspergillosis often describe:

“A tickle that turns into a spasm I can’t stop.”
“People think I’m ill, but it’s just the air or perfume.”

This happens because your airway nerves and immune cells are already primed.
Coughing doesn’t mean you’re infectious — it’s your body’s protective reflex in overdrive.

🩺 What Helps Most

  • Optimise your aspergillosis and ABPA treatment.

  • Cough-control physiotherapy or speech therapy for nerve-related cough.

  • Airway clearance techniques for mucus.

  • Identify and avoid irritants: perfume, smoke, strong detergents, cold air.

  • Ask about biologics if inflammation remains active despite steroids.

  • Use nerve-modulating medicines only under specialist advice.

🧘 Emotional Health Matters Too

Living with a chronic cough can cause anxiety, embarrassment, and isolation.
Support from counsellors, CBT therapists, or patient groups helps manage this stress — and can actually reduce cough frequency through better relaxation and breathing control.

🌱 Key Takeaway

Chronic cough in aspergillosis isn’t “just a symptom” — it’s often a mix of airway inflammation, fungal allergy, nerve hypersensitivity, and sometimes side effects of medicines.

The good news is that every contributing factor is treatable once identified — and cough can improve significantly with the right combination of medical, physical, and environmental care.

🔗 Trusted Resources

by GAtherton

🩺 Article 1: Managing Side Effects of Aspergillosis Treatments

Subtitle: What to expect, how to recognise problems early, and when to ask for help.

💊 Why This Matters

People living with aspergillosis, bronchiectasis, or Primary Ciliary Dyskinesia (PCD) often take several medicines for months or even years.
These drugs are vital for controlling infection, inflammation, and allergic reactions — but they can also cause side effects or drug interactions.

Being aware of what’s normal, what’s not, and when to seek help helps you stay safe while getting the most from treatment.

⚗️ Antifungal Medicines

Antifungal (azole) drugs are the backbone of treatment for Chronic Pulmonary Aspergillosis (CPA) and Allergic Bronchopulmonary Aspergillosis (ABPA).
They control infection but can affect the liver, heart, or skin, so regular blood monitoring is essential.

Itraconazole (Sporanox® / generic)

Used for long-term control in CPA and ABPA.

  • Common: tiredness, nausea, ankle swelling, blurred vision.

  • Serious: yellowing skin/eyes, dark urine, shortness of breath.

  • Tips:

    • Take with a main meal or fizzy drink (acidic stomach aids absorption).

    • Avoid taking it with omeprazole or similar acid-reducing drugs, as these block absorption.

    • Have regular liver-function and drug-level blood tests.

    • Report ankle swelling or jaundice immediately.

Voriconazole (Vfend®)

Used when itraconazole isn’t effective or tolerated.

  • Common: temporary visual flashes or blurred vision, sunlight sensitivity, mild headache.

  • Serious: severe rash, blistering, or long-term skin-cancer risk from sunlight.

  • Tips:

    • Always use SPF 30+ sun cream, even in winter.

    • Avoid prolonged sun exposure.

    • Report any visual change, rash, or fatigue promptly.

    • Blood monitoring checks for safe drug levels.

Posaconazole (Noxafil®)

Used for resistant infections or as a second-line therapy.

  • Common: nausea, diarrhoea, fatigue.

  • Serious: liver inflammation, low potassium (causing muscle cramps or irregular heartbeat).

  • Tips:

    • Take with a main meal or full-fat snack.

    • Report unexplained muscle weakness or palpitations.

    • Keep up with blood tests.

Isavuconazole (Cresemba®)

A newer antifungal option that may cause fewer interactions.

  • Common: headache, mild nausea, ankle swelling.

  • Tips:

    • Continue regular liver and kidney checks.

    • Report any new swelling, fatigue, or breathlessness.

💨 Corticosteroids

(Prednisolone, Methylprednisolone, Hydrocortisone)
These reduce inflammation and allergic response in ABPA and asthma.
They are powerful — but long-term use can affect weight, mood, bones, and hormone balance.

  • Common: increased appetite, fluid retention, mood swings, difficulty sleeping.

  • Long-term: thinning bones, higher blood sugar, adrenal suppression.

  • Tips:

    • Never stop suddenly — always taper under medical advice.

    • Carry a Steroid Emergency Card.

    • Ask about bone protection (vitamin D, calcium, bisphosphonates).

    • See your GP if you feel very tired, dizzy, or unwell.

🧬 Biologic Treatments

(Mepolizumab, Benralizumab, Omalizumab)
These injection-based medicines target inflammation or allergic responses in severe asthma or ABPA.

  • Common: mild injection-site soreness, tiredness, headache.

  • Occasional: mild fever or muscle aches.

  • Serious: allergic swelling of lips, tongue, or throat.

  • Tips:

    • Record any mild reactions.

    • If you develop swelling or difficulty breathing, call 999 immediately.

💊 Long-Term Antibiotics

(Azithromycin, inhaled colomycin, tobramycin)
Used to reduce bacterial infections in bronchiectasis or PCD.

  • Common: stomach upset, diarrhoea, mild throat irritation.

  • Long-term: tinnitus or hearing loss (especially with azithromycin).

  • Tips:

    • Have periodic hearing checks.

    • Rinse mouth and nebuliser after inhaled antibiotics.

    • Report ringing in the ears, severe diarrhoea, or rash.

⚠️ Drug Interactions

Antifungal medicines (especially azoles) can interfere with many common drugs, including:

  • Steroids (e.g., prednisolone, fluticasone) — may increase steroid levels.

  • Reflux medicines (e.g., omeprazole, lansoprazole) — reduce antifungal absorption.

  • Statins and warfarin — increase risk of side effects or bleeding.

  • Some antihistamines and antibiotics — can affect heart rhythm.

These interactions can be complex — always check before starting or stopping any medication.

✅ Check it yourself:
You can use the official BNF Interactions Checker (NICE Medicines Guidance) to see if two medicines are known to interact.
Simply type the names (e.g., itraconazole and prednisolone) and it will show the risk level, what the interaction does, and what clinicians usually recommend.
If unsure, show the result to your GP, pharmacist, or hospital team — they can interpret it for your situation.

🚨 When to Seek Help

Call your specialist or GP urgently if you notice:

  • Yellowing of skin or eyes

  • Severe rash, blistering, or peeling

  • New ankle swelling or breathlessness

  • Sudden fatigue or dark urine

  • Visual changes or increased photosensitivity

  • Ringing in the ears or hearing loss

If you feel acutely unwell, do not stop your medication abruptly — contact your hospital team or emergency services.

🔗 Next read: Why Awareness Matters – Staying Safe and Confident on Aspergillosis Treatment »

by GAtherton

⚠️ Omeprazole and PPIs: What’s Behind the Recent Warning?

Recently, several newspapers – including The Mirror – reported that a “BBC doctor” had issued a warning to anyone taking omeprazole, a commonly prescribed drug for acid reflux and heartburn.
So, is this something new, or just another media scare? Let’s look at what the evidence actually says – and what it means if you’re living with aspergillosis, bronchiectasis, or other chronic lung diseases.

💊 What Are PPIs?

Proton Pump Inhibitors (PPIs) such as omeprazole, lansoprazole, and esomeprazole are medicines that reduce stomach acid.
They’re often used to:

  • Treat reflux, indigestion, or stomach ulcers

  • Protect the stomach from irritation caused by anti-inflammatory drugs or steroids

They’re very effective and widely prescribed — millions of people in the UK take them every day.

⚠️ Why the Headlines?

The recent news stories stem from a discussion on BBC Morning Live, where GP Dr Punam Krishan highlighted the potential long-term side effects of PPIs.
Although these aren’t “new discoveries”, they serve as an important reminder that long-term PPI use should be reviewed regularly.

🧠 What the Evidence Shows

Research over the past decade has shown that taking PPIs for a long time or at high doses can lead to several possible side effects:

Possible Issue What Happens Why It Matters
Infections Higher risk of gut infections such as Clostridioides difficile and bacterial overgrowth Stomach acid normally helps kill harmful bacteria; reducing it alters the balance
Changes in gut microbiome Loss of protective “friendly” bacteria May influence digestion, immunity, and inflammation
Reduced absorption of nutrients Low magnesium, iron, or vitamin B12 Can lead to tiredness, cramps, or anaemia
Bone health Slightly higher risk of fractures with very long-term use May relate to calcium absorption
Kidney and heart effects (rare) Observed in some studies Still being researched

Most of these risks are small, and for many people the benefits outweigh them — but it’s still important to make sure you’re taking the lowest effective dose and that your doctor reviews the need for it periodically.

🫁 Why It Matters for Aspergillosis and Lung Conditions

If you have aspergillosis, bronchiectasis, or Primary Ciliary Dyskinesia (PCD), there are extra reasons to think carefully about long-term PPI use:

  • Microbiome connections: The gut and lungs are linked through what’s called the gut–lung axis. Disturbances in gut bacteria can affect immune responses elsewhere in the body — possibly including the lungs.

  • Infection control: PPIs can slightly increase the risk of bacterial or fungal overgrowth in the gut. While this doesn’t directly cause lung infection, it may influence the body’s balance between helpful and harmful microbes.

  • Medication interactions: Some antifungal medicines (like itraconazole or posaconazole) rely on stomach acidity for absorption — so PPIs can reduce their effectiveness. Your specialist will usually time doses or adjust medication accordingly.

  • Reflux and aspiration: On the other hand, reflux itself can worsen lung disease if acid is inhaled into the lungs — so stopping PPIs suddenly can make things worse. Always discuss any change with your doctor first.

🩺 What You Can Do

If you take omeprazole or another PPI:

  1. Check why you’re on it – Is it for reflux, ulcer protection, or another reason?

  2. Review the dose and duration – Many people can step down to a lower dose or switch to on-demand use once symptoms are controlled.

  3. Don’t stop suddenly – Stopping PPIs abruptly can cause a rebound in acid production and make symptoms flare.

  4. Ask about alternatives – Some people can switch to H2-blockers (e.g. ranitidine-type medicines), or use lifestyle changes such as avoiding late meals, raising the bedhead, and reducing caffeine or alcohol.

  5. Discuss with your specialist team – Particularly if you’re also on antifungal or antibiotic treatments, as interactions can occur.

🧩 Key Takeaway

The recent headlines about omeprazole are not new, but they highlight a genuine issue:
PPIs are very useful drugs — but long-term use should always be reviewed to make sure the benefits outweigh the risks.

For most people, there’s no need to panic.
Just make sure you:

  • Use the lowest effective dose

  • Review your need for PPIs at least once a year

  • Discuss any concerns with your respiratory or gastroenterology team

🔗 Useful References

by GAtherton

🧬 Article 2: When Microbes Turn Hostile – The Evolutionary Pressures Behind Infection

Subtitle: Why stable colonisation sometimes shifts into active disease

Introduction

If microbes can live quietly in the lungs for years, why do they sometimes turn aggressive?
Evolutionary biology and microbiome research show that infection often develops because of environmental pressures — not by design, but as a by-product of survival in a changing ecosystem.

1. Antibiotic Pressure

Repeated antibiotic courses kill sensitive strains and leave behind resistant survivors.
These survivors often produce thicker biofilms and inflammatory molecules, which protect them but also damage airway tissue.
Over time, this selection creates harder-to-treat, more inflammatory strains.

2. Nutrient Competition

Airways are crowded ecosystems.
When nutrients run low, microbes compete by releasing toxins, proteases, and iron-scavenging molecules.
These harm competitors — and incidentally harm the lung.

3. Biofilms and Mutation

Within biofilms, bacteria and fungi evolve quickly.
Mutations can accumulate, producing hypermutator strains that are well adapted to chronic survival but also more inflammatory.

4. Host Factors

Changes in the body — reduced immunity, steroid use, diabetes, or viral infections — relax immune control.
Organisms that were previously contained can now proliferate.
Similarly, damaged or scarred airways provide sheltered niches where microbes thrive.

5. Microbiome Collapse

The healthy lung microbiome helps regulate inflammation and suppress invaders.
When broad antibiotics or infections reduce diversity, opportunists like Pseudomonas or Aspergillus can expand unchecked.

6. Collateral Damage, Not Intent

Most microbes don’t “want” to be pathogenic — they’re simply adapting to survive.
Their survival strategies (biofilms, enzymes, toxins) cause collateral damage to airway tissue.
So, pathogenicity is often an accidental consequence of survival pressure.

7. Cycles of Stability and Flare-Ups

Chronic airway diseases often follow repeating cycles:

  1. Stable colonisation – coexistence with minimal inflammation

  2. Disruption – antibiotics, viral infection, or new strain

  3. Flare-up – inflammation and tissue damage

  4. Partial recovery – new stable community forms

Each cycle leaves the microbial ecosystem slightly altered — selecting for organisms that can survive stress and immune attack.

Evolutionary Summary

Pressure Effect on Microbes Result for Host
Antibiotics Resistant, stress-adapted strains Harder-to-treat infection
Nutrient limitation Toxin and enzyme producers Tissue damage
Immune suppression Less control of microbes Opportunistic growth
Microbiome loss Opportunist expansion Reduced resilience
Biofilm evolution Genetic drift, persistence Chronic inflammation

Key Takeaway

Microbes evolve under pressure from antibiotics, immune stress, and competition.
They don’t plan to harm the host — they adapt to survive.
Unfortunately, those same adaptations often make them more damaging and persistent.

This is why good airway care, careful antibiotic use, and microbiome-friendly approaches are essential to keep the system in balance.

👉 Read also: Colonisation vs Infection in Airways Disease
(Learn how to recognise the difference, when treatment is needed, and how to keep microbial balance.)

by GAtherton

🩺 Article 1: Colonisation vs Infection in Airways Disease

Subtitle: Understanding what it means when bacteria or fungi are found in your lungs

Introduction

People with bronchiectasis, Primary Ciliary Dyskinesia (PCD), Allergic Bronchopulmonary Aspergillosis (ABPA), or Chronic Pulmonary Aspergillosis (CPA) often have microbes detected in their sputum samples.
That doesn’t always mean there’s an infection that needs treatment.
Understanding the difference between colonisation and infection helps patients and clinicians make better decisions.

Colonisation

Colonisation means that bacteria or fungi are living in the airways but aren’t currently causing harm.
This happens because mucus clearance is reduced, allowing microbes such as Haemophilus influenzae, Pseudomonas aeruginosa, or Aspergillus fumigatus to persist.

  • The microbes are “residents,” not invaders.

  • Symptoms stay stable.

  • Blood tests for inflammation (like CRP) are usually normal.

Treatment isn’t always needed — instead, care focuses on airway clearance, physiotherapy, hydration, and monitoring through sputum cultures.

Infection

Infection means microbes are actively causing inflammation and tissue irritation.
This happens when microbial numbers rise, new strains appear, or immune defences weaken.

Typical signs:

  • Increased cough, sputum, or breathlessness

  • Fever or feeling unwell

  • Raised inflammatory markers

  • New changes on chest X-ray or CT

Treatment involves targeted antibiotics or antifungals based on sputum results and resistance testing.

Why Colonisation Can Turn Into Infection

In chronic airways disease, colonisation and infection exist on a sliding scale — a shift in balance can push the lungs from stable to inflamed.
Common triggers include:

  • Growth of a new or resistant strain

  • Reduced mucus clearance

  • Viral infections (e.g. influenza, COVID-19)

  • Immune suppression

  • Loss of “friendly” bacteria in the lung microbiome

When this balance is disrupted, inflammation rises and infection takes hold.

The Balance Model

Factor Colonisation (Stable) Infection (Flare-Up)
Microbial strain Stable New or virulent
Microbial load Controlled Increased
Microbiome Diverse Reduced diversity
Immune status Balanced Suppressed or overactive
Symptoms Stable Worsening
CRP / WBC Normal Raised

Key Takeaway

In chronic lung conditions, microbes are often part of daily life. The aim isn’t complete eradication, but balance — keeping numbers low, reducing inflammation, and treating only when infection is active.

👉 Next article: When Microbes Turn Hostile – The Evolutionary Pressures Behind Infection
(Explore how antibiotics, competition, and disrupted microbiomes drive microbes to become more aggressive.)

by GAtherton

🏠 Awaab’s Law: What It Means for Social Housing Tenants

Awaab’s Law is one of the most important housing reforms in years.
It aims to protect tenants from damp, mould and unsafe living conditions — problems that can seriously affect health, especially for people with asthma, bronchiectasis or fungal lung disease.

The law starts to take effect in October 2025 and is named in memory of Awaab Ishak, a two-year-old who tragically died from prolonged exposure to damp and mould in a housing association flat in Rochdale.
His case led to new, legally enforceable time limits for social landlords to investigate and repair health hazards in rented homes.

📜 Where the Law Comes From

Awaab’s Law forms part of the Social Housing (Regulation) Act 2023.
It adds a new legal duty (Section 10A) to the Landlord and Tenant Act 1985, requiring every social landlord to comply with “prescribed requirements” about how quickly hazards must be investigated and repaired.

These rules are set out in the Awaab’s Law Regulations, published on GOV.UK, and enforced by the Regulator of Social Housing.

👥 Who the Law Covers

Awaab’s Law applies to:

  • Social landlords in England, such as housing associations and local authorities

  • Tenants living in social housing under secure, assured, or introductory tenancy agreements

Awaab’s Law does not yet apply to:

  • Private landlords or the private rented sector (PRS)

  • Owner-occupiers or leaseholders

The Government has confirmed that lessons from this law will inform future private-rented-sector reforms.
(Official source: GOV.UK – Awaab’s Law Guidance)

🏘️ What Is Social Housing?

Social housing is housing owned or managed by public or not-for-profit organisations and rented out at below-market rates to people in housing need.
It provides secure, long-term homes and is regulated by the Regulator of Social Housing.

(Official source: Regulator of Social Housing – GOV.UK)

🧱 Who Provides It

  • Local authorities (councils) – council housing

  • Housing associations – independent, not-for-profit registered providers

  • Charitable or community landlords – smaller providers that must still meet national standards

These organisations are known as registered providers under the Housing and Regeneration Act 2008.

💰 How Social Housing Differs from Other Tenancies

Feature Social Housing Private Rented Housing Shared Ownership / Leasehold
Who owns it Council / housing association Private landlord / company Part tenant part provider
Rent level Below market (50–80%) Market rate Rent on unsold share + mortgage
Tenancy type Secure / assured (long-term) Assured shorthold (short-term) Leasehold ownership
Regulation Regulator of Social Housing Local authority & housing law Leasehold law
Repair standards Decent Homes Standard + Awaab’s Law General HHSRS duties As defined in lease
Who qualifies Based on housing need Anyone meeting market criteria Specific financial criteria

⚙️ What Landlords Must Do Under Awaab’s Law

Social landlords must:

  1. Investigate reported hazards quickly

  2. Provide written findings after inspection

  3. Repair and make safe within legal deadlines

  4. Offer temporary accommodation if the home cannot be made safe in time

These duties cover damp and mould and any emergency hazard posing serious risk to health or safety.

🕒 Timeframes Landlords Must Follow

Stage Time Allowed Example
Emergency hazard Make safe immediately / within 24 hours Gas leak, severe mould, electrical fault
Significant hazard Investigate within 10 working days Damp, cold, structural issues
Tenant update Written summary within 3 working days Explain findings + repairs
If not safe in time Provide alternative accommodation Until repairs complete

(Source: GOV.UK – Draft Guidance)

💬 Why Mould and Damp Matter

Damp and mould are common and dangerous in UK housing and can worsen or trigger asthma, ABPA, CPA, and COPD.
The English Housing Survey (2023) found 1 in 10 social homes had damp or mould problems.

Mould exposure can cause:

  • Asthma flare-ups and new respiratory infections

  • Worsening of fungal lung disease

  • Eye, throat, and skin irritation

Awaab’s Law recognises that poor building design and ventilation, not “tenant lifestyle,” are usually to blame.

🏘️ Why Shared and Multiple-Occupancy Homes Are Higher Risk

Buildings converted into Houses in Multiple Occupation (HMOs) are prone to damp and mould because they:

  • House many people in small spaces

  • Were often converted without proper ventilation or insulation

  • Rely on multiple tenants to report and manage repairs

HMOs are mainly in the private rented sector and not covered by Awaab’s Law.
They are regulated separately under the Housing Act 2004 and inspected by councils using the Housing Health and Safety Rating System (HHSRS).

These homes frequently house students, low-income workers, and people with chronic illness, making damp-related respiratory illnesses a particular concern.

🧱 Why HMOs Need Stronger Oversight

Local authorities can issue Improvement Notices or prosecute landlords for neglecting repairs, but Awaab’s Law’s fixed deadlines do not yet apply.
Government statements indicate future reforms will extend similar protections to private and HMO tenants.

💬 Why This Matters for Health

For anyone with chronic lung disease (ABPA, CPA, asthma, bronchiectasis), damp and mould can trigger flare-ups and new infections.
Awaab’s Law now forces social landlords to act promptly within set legal time limits.

Tenants can:

  • Use the landlord’s complaints procedure

  • Contact the Housing Ombudsman Service

  • Report serious risks to the Regulator of Social Housing or local council

🏛️ Does Awaab’s Law Apply to MOD, NHS, and Other Service Housing?

No — not directly.
Awaab’s Law covers registered social housing providers in England (local authorities and housing associations).
It does not extend to housing owned or managed by the Ministry of Defence (MOD), NHS Trusts, or other public-service employers, unless they are formally registered social landlords (which is rare).

Housing Type Covered by Awaab’s Law? Notes
Council / Housing Association Homes ✅ Yes Registered providers under the Regulator of Social Housing
Private Rented Sector ❌ No (not yet) May be included in future reforms
MOD (Service Family Accommodation) ❌ No Managed by Defence Infrastructure Organisation; standards set by policy, not law
NHS Staff Accommodation ❌ No Governed by occupational licence terms and health & safety law
University or Key Worker Housing ❌ No Treated as private or institutional housing
Charitable / Supported Housing ⚠️ Sometimes Only if registered with the Regulator of Social Housing

These providers must still maintain safe conditions under Health and Safety law, but they do not yet have the same legal repair timescales as social landlords.
The Government has stated that principles from Awaab’s Law may be used to improve MOD and NHS housing standards in future.

(Sources: legislation.gov.uk, GOV.UK – Awaab’s Law Guidance, Parliament.uk HCWS423)

🧩 Summary

Key Point What It Means
Who it covers Tenants in social housing (England only)
What it covers Damp, mould, and serious health hazards
When it starts From 27 October 2025
Who it excludes Private, MOD, NHS and service housing
Why it matters Protects tenants from unsafe homes and poor health
Who enforces it Regulator of Social Housing / Local Authorities
Official sources GOV.UK / legislation.gov.uk / Parliament.uk

🔗 Official References

by GAtherton

🧠 Can Aspergillosis Spread to the Brain?

You may have read headlines saying “Aspergillosis can spread to the brain and is one of the world’s deadliest fungal infections.”
That sounds frightening — but here’s what’s really known.

💬 The truth behind the headline

It’s true that the Aspergillus fungus can affect the brain, but this is very rare and happens only in people who are severely unwell or have very weak immune systems (for example, after chemotherapy, bone-marrow transplant, or very high-dose steroids for long peroids).

For most people with aspergillosis — whether allergic (ABPA) or chronic (CPA) — the infection stays in the lungs or sinuses. These forms do not usually spread to other parts of the body.

⚙️ How brain infection can happen

When it does occur, the fungus can reach the brain in two ways:

  1. Through the bloodstream — from an invasive infection in the lungs.

  2. By direct spread from the sinuses — through the bone between the sinuses and the brain.

These situations are very unusual and normally occur in patients whose immune defences are severely damaged.

📉 How common is it?

CNS (brain) aspergillosis makes up only a small fraction of all cases worldwide.
Even in high-risk hospital patients, it affects fewer than 1 in 10 people with invasive aspergillosis.
In people with allergic or chronic forms like ABPA or CPA, it’s almost unheard of.

❤️ What this means for you

If you have ABPA or CPA, the fungus in your lungs is not invading tissue in the same way.
It causes inflammation, allergy, or slow-growing cavities, but not deep invasion into blood vessels or brain tissue.
So, the risk of it spreading to the brain is extremely low.

Keep up with your usual care, medications, and check-ups — these control the lung disease and help prevent complications.

⚠️ When to seek medical advice

Contact your doctor urgently if you ever notice:

  • New or severe headaches

  • Changes in vision

  • Seizures or sudden weakness

  • Confusion or loss of balance

These symptoms are not common, but they’re always worth checking.

✅ Bottom line

The media headline is partly true — aspergillosis can reach the brain, but this happens almost only in people who are very immunocompromised.
For patients with ABPA or CPA, it is extremely rare and not something to fear day-to-day.

by GAtherton

Damp, Mould and Health: Be Careful About Unvalidated Tests and “Detox” Treatments

Updated 2025 – by the NAC CARES team

When you’re desperate for answers

If you live in a damp or mouldy home and your health has suffered, it’s natural to want clear answers. Many people experience coughing, fatigue, sinus trouble or breathing problems and wonder if mould exposure could be the cause.

Unfortunately, the internet is full of misleading claims about “toxic mould”, “biotoxin illness”, or “mould detox”. Some websites and private clinics sell unvalidated medical tests or promote expensive supplements claiming to “flush mould toxins” or “reverse mould illness”.

People often turn to these options out of frustration and desperation when they feel ignored or dismissed by health or housing services. But it’s important to know that these tests and products are not scientifically proven — and in some cases, they may cause harm.

The truth about “mould illness” testing

At present, there is no validated medical test that can prove a person is ill because of mould exposure in their home.

Tests often sold online or through private clinics — such as urine mycotoxin tests, mould antibody panels, or chronic inflammatory response syndrome (CIRS) profiles — are not recognised by the NHS, NICE, or the World Health Organization.

These tests may detect trace amounts of mould-related compounds that appear even in healthy people. There are no agreed normal or abnormal levels, and results can vary dramatically between labs. This means a “positive” test result does not prove illness or guide treatment.

When functional, integrative, or alternative practitioners use these tests

It’s not just online sellers. Some functional medicine, integrative health, or alternative practitioners — including some with medical or allied health qualifications — also use these same mould or mycotoxin tests in private practice.

They may genuinely want to help and believe in “root cause medicine,” but:

  • Many of these tests have never been validated in peer-reviewed clinical studies.

  • Their results cannot reliably distinguish between normal environmental exposure to fungi and actual infection or allergy.

  • People are sometimes told they have “mould toxicity” or “mycotoxin poisoning” without any scientific evidence.

Why this matters

  • It can lead to unnecessary fear and anxiety.

  • Patients may spend hundreds or thousands of pounds on testing, supplements, or “detox” treatments that do not work.

  • Most importantly, genuine medical conditions — like aspergillosis, asthma, or COPD — may be diagnosed late or missed entirely.

Even if the practitioner sounds credible, unvalidated tests remain unvalidated.
If it isn’t approved by NICE, the NHS, or recognised respiratory specialists, it isn’t a reliable diagnostic test.

The risks of “detox” and self-treatment

Many websites and practitioners also recommend “detox” products such as activated charcoal, bentonite clay, chlorella, ozone therapy, or special anti-fungal diets. None of these have been proven to remove mould or mycotoxins from the body.

Some are unsafe or can interact dangerously with prescribed medicines — especially antifungal or steroid treatments used for aspergillosis. Others can damage the gut, lungs or kidneys.

No supplement, spray, or air treatment can replace medical therapy or proper repair of damp housing.

Why these products are still allowed to be sold

These tests and supplements often remain on sale because of regulatory loopholes:

  • They’re marketed as “wellness” or “informational” tests rather than diagnostic tools.

  • Supplements are classed as foods, not medicines — they must be safe, but not proven effective.

  • Many sellers are based overseas, outside UK or EU enforcement.

That’s why public awareness is crucial. Legal does not mean scientifically valid.

If you see misleading health claims, you can report them to:

What is proven to help

Here’s what current evidence supports:

  • Talk to your NHS doctor or respiratory specialist. They can arrange validated tests for fungal disease and lung health.

  • Fix the source of damp or mould. That’s the key to protecting your health — not detox kits.

  • Seek help early from housing officers, environmental health, or Citizens Advice if your home is unsafe.

  • Work with your care team — they can support housing letters or referrals if damp is affecting your condition.

See our practical guides:

If you feel dismissed or desperate

You’re not alone. Many people living in damp conditions feel frustrated and unheard. But unvalidated tests and detox programmes will not provide the answers you deserve.
You will get more meaningful, safer support through:

🛡️ Why We Take a Cautious Approach

Some people wonder whether organisations like ours are “allied to big pharma” or dismiss alternative approaches because of financial or legal pressures.

The truth is: we are cautious because of evidence and patient safety, not loyalty to industry.

  • We recommend only treatments or tests that are scientifically proven to be safe and effective.

  • NHS and charity organisations must follow regulatory standards and cannot endorse unvalidated products.

  • Our priority is protecting patients from harm, wasted resources, and delays in care.

Being cautious doesn’t mean rejecting innovation. If a new antifungal therapy, dietary approach, or environmental test is genuinely effective, it will be validated through peer-reviewed research — and we will share it.

Until then, our guidance focuses on evidence-based medicine and environmental interventions, because those are proven to help people with aspergillosis.

Key message

Damp and mould can make you unwell — but there is no quick test, no secret biomarker, and no miracle detox that can prove or cure it.
Stick with evidence-based medicine, protect your living environment, and seek support from trustworthy sources.

Save your money, protect your health, and trust science.

by GAtherton

When Sleep Won’t Come: Coping with Anxiety and Restless Nights in Aspergillosis

“My GP prescribed 5 mg diazepam. I’m desperate for sleep. Could I take more than this, do you think?” — R, ABPA patient

R’s words echo the experience of many people living with aspergillosis. Between breathlessness, coughing, and the anxiety that chronic illness brings, nights can become long, restless, and exhausting. Sleep problems are one of the most common — and most distressing — challenges faced by people with Aspergillus-related lung disease.

But when medication doesn’t seem to help, it’s important to know what’s safe and what other strategies might make a difference.

💊 Understanding Diazepam and Sleep Medication

Diazepam (Valium) is sometimes prescribed by GPs to help with acute anxiety or severe insomnia. However, it’s a powerful sedative, and taking more than prescribed can be dangerous — leading to confusion, slowed breathing, or even overdose, especially if mixed with alcohol or other medications.

If your prescribed dose isn’t helping, don’t increase it on your own. Contact your GP or specialist nurse; they can safely adjust your treatment or explore alternative medications that are gentler and more effective for long-term sleep support.

🌙 Safer, Soothing Sleep Strategies

While medication can help in the short term, many people with aspergillosis find that calming the body and mind before bed can make a big difference over time.

🫁 1. The 4–7–8 Breathing Technique

  • Inhale quietly through your nose for 4 seconds

  • Hold for 7 seconds

  • Exhale slowly through your mouth for 8 seconds
    Repeat several times — this pattern lowers your heart rate and helps trigger your body’s relaxation response.

🧘 2. Progressive Muscle Relaxation

  • Start from your toes: tense the muscles for 5 seconds, then release.

  • Move upward through your body — legs, stomach, shoulders, face.
    This can reduce muscle tension from coughing or pain, and helps the mind unwind.

🧠 3. Grounding Exercise (5–4–3–2–1)

If anxiety or breathlessness make your thoughts spiral:

  • 5 things you can see

  • 4 things you can touch

  • 3 things you can hear

  • 2 things you can smell

  • 1 thing you can taste
    This brings your attention gently back to the present moment.

🛏️ 4. Your Sleep Environment

  • Keep lights dim and screens off before bed.

  • Try a cool, comfortable room (around 18°C).

  • Avoid clock-watching — it increases stress.

  • Gentle background noise, like soft music or a fan, can help mask coughing or household sounds.

❤️ When to Reach Out

If you’re still struggling, please reach out for help — to your GP, specialist team, or the Aspergillosis Trust or NAC Patient Support Group.
And if you ever feel overwhelmed or hopeless, you’re not alone. In the UK, you can call Samaritans (116 123) for free, 24 hours a day.

As R’s story reminds us, it’s okay to feel desperate for rest — but help is available, and there are safe, gentle ways to support your body and mind until better nights return.

by GAtherton